Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

American journal of cancer research(2022)

引用 0|浏览0
暂无评分
摘要
[This corrects the article on p. 688 in vol. 10, PMID: 32195036.].
更多
查看译文
关键词
trastuzumab resistance,breast cancer,pd1 blockade,antigen,anti-her
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要